Five-year disease-free survival in FIGO IA stage endometrial cancer patients: Tertiary institution experience in a developing country
Open Access
- 1 January 2023
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Journal of Contemporary Brachytherapy
- Vol. 15 (5) , 297-307
Abstract
Purpose: Endometrial cancer is characterized as histopathological, molecular, genetic, biological, and very diverse group of malignancies. Due to the need to precisely define the indications for adjuvant treatment in recent years, there has been a division made according to risk groups based on...Keywords
This publication has 36 references indexed in Scilit:
- A suggested modification to FIGO stage I endometrial cancerGynecologic Oncology, 2014
- Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trialThe Lancet, 2010
- Intravaginal Brachytherapy in FIGO Stage I Low-Risk Endometrial CancerInternational Journal of Gynecological Cancer, 2009
- Timing of births and endometrial cancer risk in Swedish womenCancer Causes & Control, 2009
- Revised FIGO staging for carcinoma of the endometriumInternational Journal of Gynecology & Obstetrics, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- ICRU REPORT 38: HAS THE RADIATION ONCOLOGY COMMUNITY ACCEPTED IT?Clinical Oncology, 2002
- Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trialThe Lancet, 2000
- Comprehensive QA for radiation oncology: Report of AAPM Radiation Therapy Committee Task Group 40Medical Physics, 1994
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987